As I write this, the remaining days...

As I write this, the remaining days of the secondary session of the 108th US Congres are dwindling before the election reces and time is running disclosed for action on bills that would affect the regulation of dietary counterparts (Bills that have not been acted upon in a given session of Congres do not carry athwart to the following session and ne to be reintroduced.) by means of the time you read this, the same or more of these bills may have passed, and in my nearest column, I will provide a recap of what happened as the 108th Congres wrapped up its final session.

Andro Action?

common bill that stands a better-than-average chance of passage this year is the Anabolic Steroid sway Act of 2004, S. 2195 This Senate bill would effectively prohibit the sale of certain steroid hormone precursors, like as androstenedione, by adding them to the list of controll substances. smooth though the Food and unsalable article Administration (FDA) has recently determined that andro is not a legal dietary counterpart the controversy continues--and it is damaging the industry, the agency and the athletes who could be banned from competition for using similar products. This legislation would extremity the controversy.

s 2195 also contains a provision that not liables the dietary ingredient DHEA--a prohormone will little or no potential for abuse as a performance-enhancing ingredient, moreover with demonstrated value in supporting normal hormone of the same heights during aging. A similar bill to s 2195, H.R. 3866, which was passed on the House of Representatives this past spring, also contains a DHEA exemption. the couple of these bills are supported by way of the leading dietary supplement trade associations, including mine.

Adverse consequence Reporting

Another relatively late-breaking legislative growth concerns disclosure to the regulation of adverse experiences related to the use of dietary correlatives As background, under current federal regulations, dietary fill up manufacturers are encouraged--but not required--to run over the FDA if they learn about a negative experience that could potentially be joined to the use of common of their products. Manufacturers of over-the-counter drags also are not required to report adverse facts unless their product was originally available no other than by prescription. Only prescription mix with drugs manufacturers must report any adverse experiences associated with the use of any of their products

While the Senate was considering the Department of Defense spending bill just before Congres adjourned in August, Sen Richard Durbin (D-Ill.) attempted to attach an amendment to the legislation that would have required dietary correlative manufacturers who sold their proceedss on military bases to report adverse occurrences Sens. Orrin Hatch (R-Utah) and Tom Harkin (D-Iowa) argued that legislation concerning the reporting of adverse facts was a broader issue that should not be limited simply to the armed services, and they introduced their hold amendment.

Although Durbin is individual of the Senate's most unreserved critics of dietary supplements, and Hatch and Harkin are healthy proponents, the three senators agreed to withdraw their respective amendments and collaboratively draft of the present day legislation. This legislation was still being drafted at the time of this writing. However, the fundamental note component of this bill, if introduced, will mandate that manufacturers of the couple dietary supplements and over-the-counter mix with drugss report to the government any serious adverse experiences associated with their products

The dietary supply industry as a whole is supportive of this effort and apply the minds forward to seeing such legislation.

DSHEA incline differentlys 10

It was l0 years ago in October that the Dietary addition Health and Education Act (DSHEA) was signed into law. And although the merits of the law have been debated at various times since its passage, it was no other than last year that legislative attempts to change DSHEA began. In that regard, DSHEA is not unusual. Bills are many times revisited several years after they were enacted to determine for what cause effective they've been and whether change is needinessed The effectiveness of any law is tied to a variety of factors. Bills wait to be broadly written to allow for flexibility in their enactment, on the other hand this can also lead to confusion, about the exact intent of Congres In addition, the agency charged with implementing and enforcing a law may not have the will or the wherewithal to carry without its duties.

In DSHEA's case, its supporters in the two Congress and the industry believe that it's a serviceable law that has never been to the full implemented the way Congress intended. I believe many of the criticisms that DSHEA has endur petiole from the fact that the FDA has been dull to carry out certain provisions of the law--such as introducing a well adapted manufacturing practices regulation--and to use its power to transfer products from the market, as happened earlier this year in the eases of ephedra and androstenedione.

To make secure that the law itself, if not the spirit of it, remains intact, several dietary supply manufacturers and trade associations have banded together to create the Coalition to protect DSHEA. This group, which I am fortunate enough to head, is dedicated to educating members of Congres about the important benefits that DSHEA has provided to the health of all Americans.